Carvedilol and its combination with digoxin for heart rate control in patients with persistent atrial fibrillation and chronic heart failure

Carvedilol and its combination with digoxin for heart rate control in patients with persistent atrial fibrillation and chronic heart failure

Aim. To compare effectiveness of carvedilol as monotherapy and in combination with digoxin for heart rate (HR) control in patients with persistent atrial fibrillation (AF) and chronic heart failure (CHF). Material and methods. In total, 45 men and women, aged 42-77 years, with persistent AF and NYHA...

Full description

Bibliographic Details
Main Authors:	S. N. Tereshchenko, N. G. Chuich, M. N. Morozova, A. G. Kochetkov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 1970-01-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	atrial fibrillation chronic heart failure beta-adrenoreactivity carvedilol digoxin
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1582

Similar Items

Bisoprolol and sotalol for maintaining sinus rhythm in patients with paroxysmal atrial fibrillation and chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (2005-12-01)

Digoxin for Atrial Fibrillation in Spinal Anesthesia
by: Maryam Vosoughian, et al.
Published: (2024-03-01)

OPTIMIZATION OF THE HEART RATE CONTROL IN ATRIAL FIBRILLATION BY MONITORING OF THE DIGOXIN CONCENTRATION IN ELDERLY PATIENTS
by: S. F. Zadvorev, et al.
Published: (2018-07-01)

MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. F. Zadvorev, et al.
Published: (2018-05-01)

STUDYING THE FEATURES OF BETA-ADRENOREACTION IN PATIENTS BEFORE AND AFTER INTERVENTIONAL TREATMENT OF ATRIAL FIBRILLATION
by: E A Archakov, et al.
Published: (2023-09-01)

A case of sudden slow heart rate in a patient with atrial fibrillation – what could be the possible cause?
by: Jin Yi Goh, et al.
Published: (2023-07-01)

Ivabradine could not decrease mitral regurgitation triggered atrial fibrosis and fibrillation compared with carvedilol
by: Wei‐Chieh Lee, et al.
Published: (2024-02-01)

New perspectives of recurrent atrial fibrillation prevention in coronary heart disease patients
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

The comparative analysis of the influence of bisoprolol and carvedilol on the course of heart failure of ischemic origin in patients with concomitant atrial fibrillation and diabetes mellitus
by: N.M. Kulaiets, et al.
Published: (2024-11-01)

Treatment with Digoxin – is it a clinical challenge? A Retrospective Analysis of Hospitalizations due to Digoxin intoxication
by: Marcin Wais, et al.
Published: (2024-04-01)

Incidence of All-Cause, Cardiovascular, and Atrial Fibrillation-Related Hospitalizations
by: Danilo Menichelli, MD, et al.
Published: (2024-08-01)

Stone heart syndrome: A curious case of digoxin toxicity and calcium infusion
by: Guleid Hussein, et al.
Published: (2024-09-01)

BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL
by: A. N. Zakirova, et al.
Published: (2016-01-01)

Outcomes of beta-blocker pharmacotherapy in patients with heart failure
by: Maletin Sanja D., et al.
Published: (2024-01-01)

THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION
by: A. N. Zakirova, et al.
Published: (2017-12-01)

Association of polymorphic variants of ADRB1 gene with contractile myocardial dysfunction and erythrocyte adrenoreactivity in patients with rhythm disorders
by: S. A. Afanasiev, et al.
Published: (2019-08-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

THE EFFECTIVENESS OF CARVEDILOL AND EPROSARTAN IN PATIENTS WITH METABOLIC SYNDROME AND CHRONIC HEART FAILURE
by: R. L. Dashnamirov
Published: (2014-04-01)

The effects of digoxin on heart failure mortality and re-admission in a single center cross-sectional study
by: Mahsa Behnemoon, et al.
Published: (2024-09-01)

What Is the Optimal Digoxin Level? Challenging Case of Fetal Atrial Flutter Treatment in a Monochorionic Diamniotic Twin
by: Soo Jung Kim, et al.
Published: (2023-06-01)

Safety profile of intravenous digoxin in Chinese patients with acute heart failure with reduced ejection fraction: a small-scale prospective cohort study
by: Xintian Liu, et al.
Published: (2023-11-01)

Atrial fibrillation after heart transplantation
by: M. Kh. Lepshokova, et al.
Published: (2018-03-01)

BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
by: I. T. Murkamilov, et al.
Published: (2017-07-01)

Severe digoxin intoxication: A case report of the use of digoxin-specific Fab antibody fragments
by: Tadej Petreski, et al.
Published: (2023-08-01)

Study on Neurotoxic effects of Digoxin different doses in mice
by: Farrah R. Jaafar
Published: (2017-12-01)

Heart failure and atrial fibrillation: updates and perspectives
by: V. N. Larina, et al.
Published: (2022-08-01)

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
by: Tobias Schupp, et al.
Published: (2022-08-01)

Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension
by: Kevin Y. Chang, et al.
Published: (2023-03-01)

The clinical condition and functional performance of the heart in patients with persistent atrial fibrillation after electrical cardioversion.
by: K. А. Pysarevska
Published: (2016-03-01)

The clinical condition and functional performance of the heart in patients with persistent atrial fibrillation after electrical cardioversion
by: Pysarevska K.О.
Published: (2016-03-01)

COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Predictors of paroxysmal thyrotoxic atrial fibrillation
by: L. N. Berestennikova, et al.
Published: (2011-10-01)

Evaluation of ST2 as an early marker of heart failure with a preserved left ventricular ejection fraction in patients with persistent atrial fibrillation
by: E. A. Polyanskaya, et al.
Published: (2020-02-01)

Comparison of cryoablation success in persistent and paroxysmal atrial fibrillation: single center experience
by: Naci Babat, et al.
Published: (2020-02-01)

Appropriateness of digoxin level monitoring
by: MR Mordasini, et al.
Published: (2002-09-01)

ATRIAL FIBRILLATION AND HEART FAILURE: APPROACHES TO ANTITHROMBOTIC THERAPY
by: B. A. Tatarsky, et al.
Published: (2017-08-01)

Fluid retention in patients with paroxysmal and permanent atrial fibrillation and heart failure
by: V. V. Kirillova, et al.
Published: (2020-11-01)

Metabolomics and Biomarkers for Paroxysmal and Persistent Atrial Fibrillation
by: Li‐Li Zhang, et al.
Published: (2024-02-01)